Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$144.38 - $157.78 $132,252 - $144,526
916 Added 7.8%
12,659 $1.85 Million
Q1 2024

May 07, 2024

BUY
$155.22 - $162.74 $69,849 - $73,233
450 Added 3.98%
11,743 $1.86 Million
Q4 2023

Feb 08, 2024

SELL
$145.6 - $158.88 $57,948 - $63,234
-398 Reduced 3.4%
11,293 $1.77 Million
Q3 2023

Nov 09, 2023

SELL
$155.75 - $174.48 $3,115 - $3,489
-20 Reduced 0.17%
11,691 $1.82 Million
Q2 2023

Jul 26, 2023

SELL
$154.35 - $166.11 $28,863 - $31,062
-187 Reduced 1.57%
11,711 $1.94 Million
Q1 2023

Apr 17, 2023

SELL
$151.05 - $180.26 $26,735 - $31,906
-177 Reduced 1.47%
11,898 $1.84 Million
Q4 2022

Jan 13, 2023

BUY
$160.2 - $179.79 $15,699 - $17,619
98 Added 0.82%
12,075 $0
Q3 2022

Oct 20, 2022

BUY
$161.33 - $179.52 $32,104 - $35,724
199 Added 1.69%
11,977 $1.96 Million
Q2 2022

Jul 12, 2022

SELL
$168.19 - $186.01 $77,367 - $85,564
-460 Reduced 3.76%
11,778 $2.09 Million
Q1 2022

Apr 21, 2022

BUY
$158.14 - $179.59 $36,214 - $41,126
229 Added 1.91%
12,238 $2.17 Million
Q4 2021

Feb 11, 2022

BUY
$155.93 - $173.01 $711,352 - $789,271
4,562 Added 61.26%
12,009 $2.05 Million
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $270,512 - $300,612
-1,675 Reduced 18.36%
7,447 $1.2 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $155,174 - $166,451
973 Added 11.94%
9,122 $1.5 Million
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $251,494 - $280,098
1,643 Added 25.25%
8,149 $1.34 Million
Q4 2020

Jan 29, 2021

BUY
$137.11 - $157.38 $80,620 - $92,539
588 Added 9.94%
6,506 $1.02 Million
Q3 2020

Oct 21, 2020

SELL
$140.38 - $153.83 $404,154 - $442,876
-2,879 Reduced 32.73%
5,918 $881,000
Q2 2020

Jul 16, 2020

BUY
$128.81 - $155.51 $51,395 - $62,048
399 Added 4.75%
8,797 $1.24 Million
Q1 2020

May 14, 2020

SELL
$111.14 - $153.99 $9,780 - $13,551
-88 Reduced 1.04%
8,398 $1.1 Million
Q4 2019

Feb 13, 2020

BUY
$127.5 - $146.44 $25,627 - $29,434
201 Added 2.43%
8,486 $1.24 Million
Q3 2019

Nov 18, 2019

SELL
$126.95 - $142.14 $15,234 - $17,056
-120 Reduced 1.43%
8,285 $1.07 Million
Q2 2019

Aug 12, 2019

SELL
$131.15 - $144.24 $98,231 - $108,035
-749 Reduced 8.18%
8,405 $1.17 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $18,606 - $20,688
-148 Reduced 1.59%
9,154 $1.28 Million
Q4 2018

Feb 12, 2019

BUY
$122.84 - $147.84 $349,479 - $420,604
2,845 Added 44.06%
9,302 $1.2 Million
Q3 2018

Nov 16, 2018

SELL
$121.58 - $142.88 $446,928 - $525,226
-3,676 Reduced 36.28%
6,457 $892,000
Q2 2018

Aug 09, 2018

SELL
$119.4 - $131.76 $659,923 - $728,237
-5,527 Reduced 35.29%
10,133 $1.23 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $265,712 - $314,649
2,124 Added 15.69%
15,660 $2.01 Million
Q4 2017

Feb 26, 2018

SELL
$131.22 - $143.62 $861,328 - $942,721
-6,564 Reduced 32.66%
13,536 $1.89 Million
Q3 2017

Nov 15, 2017

BUY
$129.47 - $135.38 $2.6 Million - $2.72 Million
20,100
20,100 $2.61 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track First Heartland Consultants, Inc. Portfolio

Follow First Heartland Consultants, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Heartland Consultants, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Heartland Consultants, Inc. with notifications on news.